Literature DB >> 33905676

The proteasome and its role in the nervous system.

Fulya Türker1, Emily K Cook2, Seth S Margolis3.   

Abstract

Proteasomes are multisubunit complexes that catalyze the majority of protein degradation in mammalian cells to maintain protein homeostasis and influence the regulation of most cellular processes. The proteasome, a multicatalytic protease complex, is a ring-like structure with a narrow pore that exhibits regulated gating, enabling the selective degradation of target proteins into peptide fragments. This process of removing proteins is essential for eliminating proteins that are no longer wanted, such as unfolded or aggregated proteins. This is important for preserving cellular function relevant to brain health and disease. Recently, in the nervous system, specialized proteasomes have been shown to generate peptides with important cellular functions. These discoveries challenge the prevailing notion that proteasomes primarily operate to eliminate proteins and identify signaling-competent proteasomes. This review focuses on the structure, function, and regulation of proteasomes and sheds light on emerging areas of investigation regarding the role of proteasomes in the nervous system.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  neurodegeneration; neuronal activity; proteasome; ubiquitin-proteasome system

Mesh:

Substances:

Year:  2021        PMID: 33905676      PMCID: PMC8286317          DOI: 10.1016/j.chembiol.2021.04.003

Source DB:  PubMed          Journal:  Cell Chem Biol        ISSN: 2451-9448            Impact factor:   9.039


  177 in total

1.  A gated channel into the proteasome core particle.

Authors:  M Groll; M Bajorek; A Köhler; L Moroder; D M Rubin; R Huber; M H Glickman; D Finley
Journal:  Nat Struct Biol       Date:  2000-11

2.  The ubiquitin proteasome system acutely regulates presynaptic protein turnover and synaptic efficacy.

Authors:  Sean D Speese; Nick Trotta; Chris K Rodesch; Bharathi Aravamudan; Kendal Broadie
Journal:  Curr Biol       Date:  2003-05-27       Impact factor: 10.834

3.  Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling.

Authors:  Natura Myeku; Catherine L Clelland; Sheina Emrani; Nikolay V Kukushkin; Wai Haung Yu; Alfred L Goldberg; Karen E Duff
Journal:  Nat Med       Date:  2015-12-21       Impact factor: 53.440

Review 4.  Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities.

Authors:  Rachel J Harding; Yu-Feng Tong
Journal:  Acta Pharmacol Sin       Date:  2018-04-05       Impact factor: 6.150

5.  Degradation of huntingtin mediated by a hybrid molecule composed of IAP antagonist linked to phenyldiazenyl benzothiazole derivative.

Authors:  Shusuke Tomoshige; Sayaka Nomura; Kenji Ohgane; Yuichi Hashimoto; Minoru Ishikawa
Journal:  Bioorg Med Chem Lett       Date:  2018-01-12       Impact factor: 2.823

6.  SCRAPPER-dependent ubiquitination of active zone protein RIM1 regulates synaptic vesicle release.

Authors:  Ikuko Yao; Hiroshi Takagi; Hiroshi Ageta; Tomoaki Kahyo; Showbu Sato; Ken Hatanaka; Yoshiyuki Fukuda; Tomoki Chiba; Nobuhiro Morone; Shigeki Yuasa; Kaoru Inokuchi; Toshihisa Ohtsuka; Grant R Macgregor; Keiji Tanaka; Mitsutoshi Setou
Journal:  Cell       Date:  2007-09-07       Impact factor: 41.582

7.  The lysine 48 and lysine 63 ubiquitin conjugates are processed differently by the 26 s proteasome.

Authors:  Andrew D Jacobson; Nan-Yan Zhang; Ping Xu; Ke-Jun Han; Seth Noone; Junmin Peng; Chang-Wei Liu
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

8.  Localization of proteasomes and proteasomal proteolysis in the mammalian interphase cell nucleus by systematic application of immunocytochemistry.

Authors:  Andrea Scharf; Thomas Dino Rockel; Anna von Mikecz
Journal:  Histochem Cell Biol       Date:  2007-01-05       Impact factor: 2.531

Review 9.  Chemotherapy-Induced Peripheral Neuropathy and Changes in Cytoskeleton.

Authors:  Alessio Malacrida; Cristina Meregalli; Virginia Rodriguez-Menendez; Gabriella Nicolini
Journal:  Int J Mol Sci       Date:  2019-05-09       Impact factor: 5.923

10.  D²P²: database of disordered protein predictions.

Authors:  Matt E Oates; Pedro Romero; Takashi Ishida; Mohamed Ghalwash; Marcin J Mizianty; Bin Xue; Zsuzsanna Dosztányi; Vladimir N Uversky; Zoran Obradovic; Lukasz Kurgan; A Keith Dunker; Julian Gough
Journal:  Nucleic Acids Res       Date:  2012-11-29       Impact factor: 16.971

View more
  7 in total

Review 1.  Keeping synapses in shape: degradation pathways in the healthy and aging brain.

Authors:  Marijn Kuijpers
Journal:  Neuronal Signal       Date:  2022-06-15

Review 2.  Physiological Overview of the Potential Link between the UPS and Ca2+ Signaling.

Authors:  Dongun Lee; Jeong Hee Hong
Journal:  Antioxidants (Basel)       Date:  2022-05-19

Review 3.  Historical perspective and progress on protein ubiquitination at glutamatergic synapses.

Authors:  Angela M Mabb
Journal:  Neuropharmacology       Date:  2021-06-29       Impact factor: 5.273

Review 4.  Localized Proteasomal Degradation: From the Nucleus to Cell Periphery.

Authors:  Xing Guo
Journal:  Biomolecules       Date:  2022-01-29

5.  Upper motor neurons are a target for gene therapy and UCHL1 is necessary and sufficient to improve cellular integrity of diseased upper motor neurons.

Authors:  Barış Genç; Javier H Jara; Santana S Sanchez; Amiko K B Lagrimas; Öge Gözütok; Nuran Koçak; Yongling Zhu; P Hande Özdinler
Journal:  Gene Ther       Date:  2021-12-02       Impact factor: 4.184

Review 6.  Disease modification in Parkinsonism: obstacles and ways forward.

Authors:  M Höllerhage; M Klietz; G U Höglinger
Journal:  J Neural Transm (Vienna)       Date:  2022-06-13       Impact factor: 3.850

Review 7.  Site-Specific Proteasome Inhibitors.

Authors:  Alexei F Kisselev
Journal:  Biomolecules       Date:  2021-12-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.